These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23269112)

  • 1. Behavioral support intervention for uncontrolled hypertension: a complier average causal effect (CACE) analysis.
    Liang Y; Ehler BR; Hollenbeak CS; Turner BJ
    Med Care; 2015 Feb; 53(2):e9-e15. PubMed ID: 23269112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a peer and practice staff support intervention.
    Hollenbeak CS; Weiner MG; Turner BJ
    Am J Manag Care; 2014 Mar; 20(3):253-60. PubMed ID: 24884753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension.
    Turner BJ; Hollenbeak CS; Liang Y; Pandit K; Joseph S; Weiner MG
    J Gen Intern Med; 2012 Oct; 27(10):1258-64. PubMed ID: 22570108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of nonpharmacologic population-wide blood pressure reduction on coronary heart disease events: pronounced benefits in African-Americans and hypertensives.
    Erlinger TP; Vollmer WM; Svetkey LP; Appel LJ
    Prev Med; 2003 Oct; 37(4):327-33. PubMed ID: 14507489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot study Evaluating a Community-based Intervention Focused on the ISHIB IMPACT Cardiovascular Risk Reduction Toolkit in African American Patients with Uncontrolled Hypertension.
    Johnson W; Ezeugwu C; Monroe D; Breunig IM; Shaya F
    Ethn Dis; 2015; 25(2):162-7. PubMed ID: 26118143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of peer-delivered self-management support for hypertension.
    Whittle J; Schapira MM; Fletcher KE; Hayes A; Morzinski J; Laud P; Eastwood D; Ertl K; Patterson L; Mosack KE
    Am J Hypertens; 2014 Nov; 27(11):1416-23. PubMed ID: 24755206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Payeras AC; Sladek K; Lembo G; Alberici M
    Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of estimands in clinical trials with imperfect compliance.
    Chen H; Heitjan DF
    Int J Biostat; 2024 May; 20(1):57-67. PubMed ID: 37365674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African American Veterans Storytelling: A Multisite Randomized Trial to Improve Hypertension.
    Houston TK; Fix GM; Shimada SL; Long JA; Gordon HS; Pope C; Volkman J; Allison JJ; DeLaughter K; Orner M; Bokhour BG
    Med Care; 2017 Sep; 55 Suppl 9 Suppl 2():S50-S58. PubMed ID: 28806366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
    Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
    Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.
    Margolis KL; Asche SE; Dehmer SP; Bergdall AR; Green BB; Sperl-Hillen JM; Nyboer RA; Pawloski PA; Maciosek MV; Trower NK; O'Connor PJ
    JAMA Netw Open; 2018 Sep; 1(5):e181617. PubMed ID: 30646139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.
    Petrella RJ; Tremblay G; De Backer G; Gill DP;
    Vasc Health Risk Manag; 2014; 10():63-74. PubMed ID: 24493928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease.
    Becker DM; Yanek LR; Johnson WR; Garrett D; Moy TF; Reynolds SS; Blumenthal RS; Vaidya D; Becker LC
    Circulation; 2005 Mar; 111(10):1298-304. PubMed ID: 15769772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Patient-Centered Behavioral Economics Intervention on Hypertension Control in a Highly Disadvantaged Population: a Randomized Trial.
    Shapiro MF; Shu SB; Goldstein NJ; Victor RG; Fox CR; Tseng CH; Vangala S; Mogler BK; Reed SB; Villa E; Escarce JJ
    J Gen Intern Med; 2020 Jan; 35(1):70-78. PubMed ID: 31515735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.